SCHEMBL95773

SCHEMBL95773

Cc1ccc(Cl)c(C(N)c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.40
TDO2 P48775 4/20 0.40
IDO2 Q6ZQW0 3/20 0.40
S1PR2 O95136 1/20 0.38
S1PR4 O95977 1/20 0.38
S1PR3 Q99500 1/20 0.38
MAPT P10636 2/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SCN4A P35499 2/20 0.36
TACR1 P25103 1/20 0.36
LMNA P02545 1/20 0.36
ESR1 P03372 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
KCNE1 P15382 1/20 0.36
CHRM3 P20309 1/20 0.36
PTGS1 P23219 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17871862 0.98 IDO1 (0.41) IDO1TDO2IDO2S1PR2S1PR4
SCHEMBL14675546 0.86 IDO1 (0.41) IDO1TDO2IDO2MAPTTP53
SCHEMBL23934953 0.81 TACR1 (0.44) MAPTSMN1; SMN2TACR1LMNAESR1
Hydrochloric Acid SCHEMBL19665100 0.80 TACR1 (0.43) MAPTSMN1; SMN2TACR1LMNAESR1
SCHEMBL22927822 0.80 IDO1 (0.42) IDO1TDO2IDO2SLC6A4DPP4
SCHEMBL96016 0.80 S1PR2 (0.38) IDO1TDO2IDO2S1PR2S1PR4
SCHEMBL19665163 0.79 IDO1 (0.39) IDO1TDO2MAPTTACR1LMNA
SCHEMBL95504 0.79 MLKL (0.45) S1PR2S1PR4S1PR3MAPTLMNA
SCHEMBL27886161 0.79 CHRM1 (0.52) MAPTTP53SMN1; SMN2LMNAESR1
SCHEMBL14677950 0.78 TACR1 (0.41) MAPTSMN1; SMN2TACR1LMNASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902725-B2 Heterocyclic derivatives as RORgamma modulators GENFIT (FR) 2018-02-27 US disclosed
US-20170349582-A1 HETEROCYCLIC DERIVATIVES AS RORGAMMA MODULATORS GENFIT (FR) 2017-12-07 US disclosed
US-20170008922-A1 BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND AJINOMOTO CO., INC. (JP) 2017-01-12 US disclosed
US-9499579-B2 Branched chain-containing aromatic compound AJINOMOTO CO., INC. (JP) 2016-11-22 US disclosed
US-9371353-B2 Oligonucleotide with protected base AJINOMOTO CO., INC. (JP) 2016-06-21 US disclosed
US-20150080565-A1 OLIGONUCLEOTIDE WITH PROTECTED BASE AJINOMOTO CO., INC. (JP) 2015-03-19 US disclosed
US-8846885-B2 Oligonucleotide with protected base AJINOMOTO CO., INC. (JP) 2014-09-30 US disclosed
US-8546534-B2 Branched chain-containing aromatic compound AJINOMOTO CO., INC. (JP) 2013-10-01 US disclosed
US-20120059149-A1 BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND AJINOMOTO CO. INC. (JP) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349582-A1 HETEROCYCLIC DERIVATIVES AS RORGAMMA MODULATORS RORC, RORB, RORA IDO1 1036/4885TDO2 3421/4885IDO2 1318/4885
US-20120059149-A1 BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND VIP, BCAT2, IAPP IDO1 1454/4885TDO2 3091/4885IDO2 1195/4885
US-20150080565-A1 OLIGONUCLEOTIDE WITH PROTECTED BASE POLRMT, POLN, RNGTT IDO1 4236/4885TDO2 2373/4885IDO2 3835/4885
US-20170008922-A1 BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND VIP, IAPP, BCAT1 IDO1 742/4885TDO2 3735/4885IDO2 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.